103 related articles for article (PubMed ID: 3043383)
1. Capillary filtration in idiopathic cyclic edema--effects of Daflon 500 mg.
Behar A; Lagrue G; Cohen-Boulakia F; Baillet J
Nuklearmedizin; 1988 Jun; 27(3):105-7. PubMed ID: 3043383
[No Abstract] [Full Text] [Related]
2. Study of capillary filtration by double labelling I131-albumin and Tc99m red cells. Application to the pharmacodynamic activity of Daflon 500 mg.
Behar A; Lagrue G; Cohen-Boulakia F; Baillet J
Int Angiol; 1988; 7(2 Suppl):35-8. PubMed ID: 3053941
[TBL] [Abstract][Full Text] [Related]
3. [Effect of veinotonyl 75 on the capillary permeability test using technetium albumin in cyclic orthostatic edemas].
Behar A; Nathan P; Lavieuville M; Allaert FA
Phlebologie; 1993; 46(4):721-31. PubMed ID: 8115491
[TBL] [Abstract][Full Text] [Related]
4. Capillary filtration and lymphatic resorption in diabetes. Application to the pharmacodynamic activity of Daflon 500 mg.
Behar A; Valensi P; de Champvallins M; Cohen-Boulakia F; Albagli B
Int Angiol; 1989; 8(4 Suppl):27-9. PubMed ID: 2632646
[TBL] [Abstract][Full Text] [Related]
5. Effects of a purified micronized flavonoid fraction on capillary filtration in diabetic patients.
Valensi PE; Behar A; de Champvallins MM; Attalah M; Boulakia FC; Attali JR
Diabet Med; 1996 Oct; 13(10):882-8. PubMed ID: 8911782
[TBL] [Abstract][Full Text] [Related]
6. Capillary filtration and ankle edema in patients with venous hypertension: effects of Daflon.
Cesarone MR; Laurora G; De Sanctis MT; Belcaro G
Angiology; 1993 Jan; 44(1):57-61. PubMed ID: 8424585
[TBL] [Abstract][Full Text] [Related]
7. Clinical implications of impaired microcirculation.
Valensi P; Behar A
Int Angiol; 1995 Sep; 14(3 Suppl 1):26-31. PubMed ID: 8919261
[TBL] [Abstract][Full Text] [Related]
8. [Double isotope albumin flux measurement: diagnosis and therapeutic monitoring of acute lung injury].
Högerle S; Bräutigam P; Benzing A; Nitzsche E; Mols G; Geiger K; Moser E
Nuklearmedizin; 1997 Jun; 36(4):137-41. PubMed ID: 9289700
[TBL] [Abstract][Full Text] [Related]
9. Steroids and cerebral edema: the effects of glucocorticoids on abnormal capillary permeability following cerebral injury in cats.
Rovit RL; Hagan R
J Neuropathol Exp Neurol; 1968 Apr; 27(2):277-99. PubMed ID: 5646197
[No Abstract] [Full Text] [Related]
10. [Scintigraphic control of the vascular flow of cytostatics in regional perfusion].
Blazek J; Broz J
Cesk Stomatol; 1982 Dec; 82(6):434-7. PubMed ID: 6218910
[No Abstract] [Full Text] [Related]
11. [Treatment of mastodynia with synthetic diosmin].
Ciardetti P; Zucconi G; Ottanelli S; Casparis D
Ann Ostet Ginecol Med Perinat; 1985; 106(5):258-66. PubMed ID: 3914853
[No Abstract] [Full Text] [Related]
12. Different flavonoids present in the micronized purified flavonoid fraction (Daflon 500 mg) contribute to its anti-hyperpermeability effect in the hamster cheek pouch microcirculation.
Paysant J; Sansilvestri-Morel P; Bouskela E; Verbeuren TJ
Int Angiol; 2008 Feb; 27(1):81-5. PubMed ID: 18277344
[TBL] [Abstract][Full Text] [Related]
13. Advantage of a micronized flavonoidic fraction (Daflon 500 mg) in comparison with a nonmicronized diosmin.
Amato C
Angiology; 1994 Jun; 45(6 Pt 2):531-6. PubMed ID: 8203783
[TBL] [Abstract][Full Text] [Related]
14. [Estimation of capillary permeability by means of albumin 131 I in normal state and in edema].
Macheret H
Schweiz Med Wochenschr; 1973 Jun; 103(26):934-41. PubMed ID: 4716912
[No Abstract] [Full Text] [Related]
15. Pharmacologic properties of Daflon 500 mg.
Labrid C
Angiology; 1994 Jun; 45(6 Pt 2):524-30. PubMed ID: 8203782
[TBL] [Abstract][Full Text] [Related]
16. Technetium-99m-albumin colloid lymphoscintigraphy in postoperative lymphocele.
Perrymore WD; Harolds JA
J Nucl Med; 1996 Sep; 37(9):1517-8. PubMed ID: 8790205
[TBL] [Abstract][Full Text] [Related]
17. Retention, distribution and absorption of inhaled albumin aerosol and absorbed dose estimates from its I131 and TC99m labels.
Pircher FJ; Knight CM; Barry WF; Temple JR; Kirsch WJ
Am J Roentgenol Radium Ther Nucl Med; 1967 Aug; 100(4):813-21. PubMed ID: 4951446
[No Abstract] [Full Text] [Related]
18. Are the phlebotonic properties shown in clinical pharmacology predictive of a therapeutic benefit in chronic venous insufficiency? Our experience with Daflon 500 mg.
Tsouderos Y
Int Angiol; 1989; 8(4 Suppl):53-9. PubMed ID: 2698902
[TBL] [Abstract][Full Text] [Related]
19. [Prevention and therapy of sports injuries. Experiences with an escin-containing gel].
Pabst H; Kleine MW
Fortschr Med; 1986 Jan; 104(3):44-6. PubMed ID: 3514402
[No Abstract] [Full Text] [Related]
20. Clinical evaluation of a venotropic drug in man. Example of Daflon 500 mg.
Laurent R; Gilly R; Frileux C
Int Angiol; 1988; 7(2 Suppl):39-43. PubMed ID: 3053942
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
